Thymosin Alpha-1 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Thymosin Alpha-1 is being researched for inflammation applications. Engages Toll-like receptors (TLR) on myeloid and plasmacytoid dendritic cells, triggering MyD88-dependent signaling cascades. Drives IL-2 production, IFN-gamma stimulation, and T lymphocyte/NK cell ac. Common dosages for this use range from 1.6-6.4 mg per dose twice weekly.
Can Thymosin Alpha-1 Help With Inflammation?
Thymosin Alpha-1 (Thymosin alpha 1 (28-amino acid peptide)) is being researched for inflammation applications based on its mechanism as a Thymic peptide, immunomodulator.
Engages Toll-like receptors (TLR) on myeloid and plasmacytoid dendritic cells, triggering MyD88-dependent signaling cascades. Drives IL-2 production, IFN-gamma stimulation, and T lymphocyte/NK cell activation while promoting thymopoiesis. Simultaneously suppresses pro-inflammatory IL-6/TNF-alpha while enhancing anti-inflammatory IL-10.
What Does the Research Show for Thymosin Alpha-1 and Inflammation?
FDA-approved as orphan drug for melanoma, DiGeorge syndrome, chronic hepatitis B, and hepatocellular carcinoma. Clinical trials ongoing for lung cancer, hepatitis C, HIV, and COVID-19. Approved in 35 countries.
The relevance to inflammation specifically comes from Thymosin Alpha-1's effects on immune activation, T-cell function enhancement, antiviral response, cancer immunotherapy adjuvant.
What Protocol Is Used for Inflammation?
For inflammation applications, the standard Thymosin Alpha-1 protocol is 1.6-6.4 mg per dose administered twice weekly via subcutaneous injection for 5-7 day injection cycles, repeated as needed.
Some researchers adjust dosing based on the specific inflammation application — see our Thymosin Alpha-1 dosage guide for full protocol details.
Can Stacking Improve Inflammation Results?
Synergizes with interferons and antivirals for enhanced immune priming. Off-label stacking with checkpoint inhibitors in cancer immunotherapy.
What Side Effects Apply to Inflammation Use?
Well-tolerated. Local injection site reactions most common. Safe in liver disease, cancer, and autoimmune conditions. No significant organ toxicity.
Side effects are generally consistent regardless of the specific application. See our Thymosin Alpha-1 side effects guide for details.
Calculate Your Thymosin Alpha-1 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Thymosin Alpha-1.
Open Calculator →Bottom Line: Thymosin Alpha-1 for Inflammation
Thymosin Alpha-1 shows preliminary research potential for inflammation. Standard protocols (1.6-6.4 mg per dose, twice weekly, 5-7 day injection cycles, repeated as needed) apply.
Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.
Complete Guide
Thymosin Alpha-1 : Benefits, Dosage, Side Effects & Research
Related Reading
- Thymosin Alpha-1 Dosage Guide
- Thymosin Alpha-1 Benefits
- Thymosin Alpha-1 Side Effects
- Thymosin Alpha-1 Stacking Guide
- Thymosin Alpha-1 Cycle Guide
- Thymosin Alpha-1 Research
Research-Grade Sourcing
If you're going to research Thymosin Alpha-1, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Thymosin Alpha-1?
Thymosin Alpha-1 (Thymosin alpha 1 (28-amino acid peptide)) is a Thymic peptide, immunomodulator. Naturally occurring peptide isolated from thymus gland; synthetic form (thymalfasin/Zadaxin) developed for immune enhancement. It is researched for immune activation, T-cell function enhancement, antiviral response, cancer immunotherapy adjuvant.
What is the recommended Thymosin Alpha-1 dosage?
Common dosages: 1.6-6.4 mg per dose administered twice weekly via subcutaneous injection. Cycle length: 5-7 day injection cycles, repeated as needed. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of Thymosin Alpha-1?
Well-tolerated. Local injection site reactions most common. Safe in liver disease, cancer, and autoimmune conditions. No significant organ toxicity.
Is Thymosin Alpha-1 safe?
Thymosin Alpha-1 has shown a favorable safety profile in research. FDA-approved (Zadaxin) for specific cancer and hepatitis indications. Prescription medication. All research should follow appropriate safety protocols.